Oura's confidential SEC filing in May 2026, following its $11 billion post-money Series E valuation from October 2025, anchors trader sentiment around revenue scaling to nearly $2 billion in 2026 sales. This implies roughly 5.5x forward multiples at the latest private round, with market-implied odds favoring a $17.5–20 billion+ closing market cap at 33% combined probability due to AI enhancements, enterprise adoption including defense contracts, and favorable 2026 IPO windows. Spread outcomes reflect uncertainty over SEC review timelines, broader equity multiples for wearables, and execution risks in a competitive health-tech landscape, where comparable growth trajectories could drive re-rating or compression upon listing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$20B+ 18%
$17.5B–$20B 16%
$7.5B–$10B 14%
<$7.5B 13%
$68,818 ปริมาณ
$68,818 ปริมาณ
Jan 1, 2027
<$7.5B
13%
$7.5B–$10B
14%
$10B–$12.5B
13%
$12.5B–$15B
9%
$15B–$17.5B
13%
$17.5B–$20B
16%
$20B+
18%
No IPO before January 2027
10%
$20B+ 18%
$17.5B–$20B 16%
$7.5B–$10B 14%
<$7.5B 13%
$68,818 ปริมาณ
$68,818 ปริมาณ
Jan 1, 2027
<$7.5B
$12,980 ปริมาณ
13%
$7.5B–$10B
$20,802 ปริมาณ
14%
$10B–$12.5B
$8,456 ปริมาณ
13%
$12.5B–$15B
$6,952 ปริมาณ
9%
$15B–$17.5B
$6,051 ปริมาณ
13%
$17.5B–$20B
$6,819 ปริมาณ
16%
$20B+
$5,663 ปริมาณ
18%
No IPO before January 2027
$1,095 ปริมาณ
10%
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura's confidential SEC filing in May 2026, following its $11 billion post-money Series E valuation from October 2025, anchors trader sentiment around revenue scaling to nearly $2 billion in 2026 sales. This implies roughly 5.5x forward multiples at the latest private round, with market-implied odds favoring a $17.5–20 billion+ closing market cap at 33% combined probability due to AI enhancements, enterprise adoption including defense contracts, and favorable 2026 IPO windows. Spread outcomes reflect uncertainty over SEC review timelines, broader equity multiples for wearables, and execution risks in a competitive health-tech landscape, where comparable growth trajectories could drive re-rating or compression upon listing.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ตลาดเปิดเมื่อ: May 26, 2026, 12:28 PM ET
ปริมาณการซื้อขาย
$68,818วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura's confidential SEC filing in May 2026, following its $11 billion post-money Series E valuation from October 2025, anchors trader sentiment around revenue scaling to nearly $2 billion in 2026 sales. This implies roughly 5.5x forward multiples at the latest private round, with market-implied odds favoring a $17.5–20 billion+ closing market cap at 33% combined probability due to AI enhancements, enterprise adoption including defense contracts, and favorable 2026 IPO windows. Spread outcomes reflect uncertainty over SEC review timelines, broader equity multiples for wearables, and execution risks in a competitive health-tech landscape, where comparable growth trajectories could drive re-rating or compression upon listing.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ปริมาณการซื้อขาย
$68,818วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...Oura's confidential SEC filing in May 2026, following its $11 billion post-money Series E valuation from October 2025, anchors trader sentiment around revenue scaling to nearly $2 billion in 2026 sales. This implies roughly 5.5x forward multiples at the latest private round, with market-implied odds favoring a $17.5–20 billion+ closing market cap at 33% combined probability due to AI enhancements, enterprise adoption including defense contracts, and favorable 2026 IPO windows. Spread outcomes reflect uncertainty over SEC review timelines, broader equity multiples for wearables, and execution risks in a competitive health-tech landscape, where comparable growth trajectories could drive re-rating or compression upon listing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย